AI assistant
Immuron Ltd — Capital/Financing Update 2006
Jun 4, 2006
35121_rns_2006-06-04_e0c078fd-36f0-4541-b0dc-7e38c0c8c719.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

5 June, 2006.
The Company Announcement Office, Australian Stock Exchange Limited, Sydney. NSW.
Subject: Appendix 3B.
The following Appendix 3B is in response to the recent announcement of a share placement which is repeated below:
"ANADIS LIMITED SHARE PLACEMENT
The Board of Directors of Anadis Limited are pleased to advise that the Company has raised funds in a share placement of \$1.7 million before costs. The placement represents 6.5% of the total current shares on issue. The placement comprised 2,500,000 fully paid ordinary shares in the capital of the Company at 28 cents per share to Australian professional investors, and an additional 3,448,276 fully paid ordinary shares at 29 cents per share to an overseas institution, with 862,069 attaching options. The options have a twelve month expiry date from date of issue and an exercise price of 38 cents per option...
This placement to institutional and professional investors has been partially arranged through Intersuisse Corporate. The majority of shares have been placed to Whitney $\&$ Co, an existing institutional shareholder.
The funds raised are to be utilized for the commercial scale-up of the Enterovirus 71 program and the continued international expansion of Travelan. Key Company
+ See chapter 19 for defined terms.
executives will be travelling during June to the U.S.A, Canada, Taiwan and Singapore to further these objectives.
For Further information please contact:
Conor Graham - Managing Director & CEO or. Arie Nudel - Investor Relations
Telephone: 03 9358 6388 Facsimile: 03 9358 6399"
Anadis Limited
David Woods Company Secretary
ANADIS LIMITED ABN 80 063 114 045
4 Capital Link Drive Campbellfield Victoria Australia 3061 Ph (61) 3 9358 6388 Fax (61) 3 9358 6399 email: [email protected] website: www.anadis.com.au
+ See chapter 19 for defined terms.
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.
Name of entity
ANADIS LIMITED
ABN
80 063 114 045
We (the entity) give ASX the following information.
and due dates for payment; if
conversion price and dates for
securities,
the
Part 1 - All issues
*convertible
conversion)
You must complete the relevant sections (attach sheets if there is not enough space).
| + Class of + securities issued or to be issued |
-Listed ordinary fully paid shares -Unlisted share options |
|
|---|---|---|
| -2 | Number of "securities issued or to be issued (if known) or maximum number which may be issued |
-5,948,277 listed ordinary shares $-862,069$ unlisted options @ 0.38 with expiry date of 4 June, 2007 |
| -3 | Principal terms of the "securities" (eg, if options, exercise price and expiry date; if partly paid *securities, the amount outstanding |
- See chapter 19 for defined terms.
$\overline{4}$ Do the *securities rank equally in all respects from the date of allotment with an existing +class of quoted *securities?
If the additional securities do not rank equally, please state:
- the date from which they do
- the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
- the extent to which they do not rank equally, other than in relation to the next dividend. distribution or interest payment
- 5 Issue price or consideration
Purpose of the issue 6 (If issued as consideration for the acquisition of assets, clearly identify those assets)
3,448,276 @ 0.29.& 2,500,001 @ 0.28. Total \$1,700,000
Placement pursuant to an announcement made.
$\overline{7}$ Dates of entering *securities into uncertificated holdings or despatch of certificates
6 June, 2006
Yes
8 Number and *class $\sigma$ all *securities quoted on ASX (including the securities in clause 2 if applicable)
| Number | + Class |
|---|---|
| 98,217,403 | Ordinary |
+ See chapter 19 for defined terms.
| - 0 | Number and "class of | -all | |
|---|---|---|---|
| *securities not quoted on ASX | |||
| (including the securities in clause) | |||
| 2 if applicable) |
| Number | * Class |
|---|---|
| 700,000 | ANXAK |
| 100,000 | ANXAY |
| 100,000 | ANXAU |
| 1,600,000 | ANXAZ |
| 100,000 | ANXAB |
| 250,000 | ANXAC |
| 100,000 | ANXAD |
| 100,000 | ANXAE |
| 100,000 | ANXAF |
| 862,069 |
$10°$ Dividend policy (in the case of a $N/A$ trust, distribution policy) on the increased capital (interests)
Part 2 - Bonus issue or pro rata issue
- $11$ holder approval $\mathbf k$ security required?
- 12 Is the issue renounceable or nonrenounceable?
- 13 Ratio in which the *securities will be offered
- $14$ *Class of *securities to which the offer relates
- $15$ *Record determine date $t_{\rm O}$ entitlements
- 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?
- $17$ Policy for deciding entitlements in relation to fractions
- 18 Names of countries in which the entity has 'security holders who will not be sent new issue documents
Note: Security holders must be told how their entifiements are to be dealt with.
Cross reference: rule 7.7. 19 Closing date for receipt acceptances or renunciations

+ See chapter 19 for defined terms.
| 20 | Names of any underwriters | |
|---|---|---|
| 21 | Amount of any underwriting fee or commission |
|
| 22 | Names of any brokers to the issue | |
| 23. | Fee or commission payable to the broker to the issue |
|
| 24 | handling Amount of fee any payable to brokers who lodge acceptances or renunciations on behalf of "security holders |
|
| 25. | If the issue is contingent on *security holders' approval, the date of the meeting |
|
| 26 | Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled |
|
| 27. | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders |
|
| 28 | Date rights trading will begin (if applicable) |
|
| 29 | Date rights trading will end (if applicable) |
|
| 30 | How do *security holders sell their entitlements in full through a broker? |
|
| 31 | How do *security holders sell part of their entitlements through a broker and accept for the balance? |
+ See chapter 19 for defined terms.
- 32 How do *security holders dispose of their entitlements (except by sale through a broker)?
- 33 *Despatch date
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
$34$ Type of securities (tick one)
$(a)$
$(b)$
35
- Securities described in Part 1
- All other securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
| Tick to indicate you are providing the information or | |||||
|---|---|---|---|---|---|
| documents. |
- If the "securities are "equity securities, the names of the 20 largest holders of the additional *securities, and the number and percentage of additional *securities held by those holders
- 36 If the *securities are *equity securities, a distribution schedule of the additional "securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$
- $10,001 100,000$ 100,001 and over
37
A copy of any trust deed for the additional "securities
+ See chapter 19 for defined terms.
Entities that have ticked box 34(b)
- 38 Number of securities for which *quotation is sought
- Class of *securities for which 39 quotation is sought
- $401$ Do the "securities rank equally in all respects from the date of allotment with an existing 'class of quoted *securities?
If the additional securities do not rank equally, please state:
- $\bullet$ the date from which they do
- the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
- the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
- Reason for request for quotation $41$ now
Example: In the case of restricted securities, end of restriction period
(if issued upon conversion of another security, clearly identify that other security)
42 Number and 'class of all 'securities quoted on ASX (including the securities in clause 38)
| Number | + Class |
|---|---|
+ See chapter 19 for defined terms.
Quotation agreement
- $\mathbf{1}$ *Ouotation of our additional *securities is in ASX's absolute discretion. ASX may quote the 'securities on any conditions it decides.
- $\overline{2}$ We warrant the following to ASX.
- The issue of the *securities to be quoted complies with the law and is not for an illegal purpose.
- There is no reason why those *securities should not be granted +quotation.
- An offer of the +securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.
Note: An entity may need to obtain appropriate warranties fromsubscribers for the securities in order to be able to give this warranty
- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any "securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
- If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.
- 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
- $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before 'quotation of the 'securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
| Sign here: | ******** | Date: 5 June, 2006. |
|---|---|---|
| (Secretary) |
Print name: David Woods
$=$ $=$ $=$ $=$ $=$ $=$